A systematic review protocol of diagnostic and prognostic factors in patients with prostate cancer

Katharina Beyer* (Corresponding Author), Lisa Moris, Michael Lardas, Anna Haire, Francesco Barletta, Simone Scuderi, Eleni Vradi, Giorgio Gandaglia, Muhammad Imran Omar, Steven MacLennan, Jihong Zong, Bahman Farahmand, Sara J. MacLennan, Zsuzsanna Devecseri, Alex Asiimwe, Laurence Collette, Anders Bjartell, James N'Dow, Alberto Briganti, Mieke Van HemelrijckThe PIONEER Consortium

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Prostate cancer (PCa) is the second most common cancer worldwide 1 and accounts for 15% of all cancers diagnosed 2. Clinically localised PCa is typically characterised by a favourable long-term natural history, where several therapeutic options are available. Moreover, the treatment landscape of advanced and metastatic PCa has changed dramatically in the past decade with the approval of multiple systemic agents, improving patients’ survival.
Original languageEnglish
JournalBMJ Open
Publication statusAccepted/In press - 29 Oct 2020

Keywords

  • Prostate cancer
  • diagnostic factor
  • prognostic factors

Fingerprint Dive into the research topics of 'A systematic review protocol of diagnostic and prognostic factors in patients with prostate cancer'. Together they form a unique fingerprint.

Cite this